Free Trial

Vident Advisory LLC Invests $2.74 Million in Dolby Laboratories $DLB

Dolby Laboratories logo with Consumer Discretionary background

Key Points

  • Vident Advisory LLC has acquired 34,123 shares of Dolby Laboratories, with a total value of approximately $2.74 million, during the first quarter of the year.
  • Dolby Laboratories reported a quarterly earnings of $0.78 per share, exceeding analysts' expectations and marking a 9.2% increase in revenue year-over-year.
  • The company has declared a quarterly dividend of $0.33 per share, resulting in an annualized yield of 1.8% and a dividend payout ratio of 48.35%.
  • MarketBeat previews top five stocks to own in October.

Vident Advisory LLC purchased a new stake in Dolby Laboratories (NYSE:DLB - Free Report) in the first quarter, according to the company in its most recent disclosure with the SEC. The firm purchased 34,123 shares of the electronics maker's stock, valued at approximately $2,740,000.

A number of other institutional investors have also recently made changes to their positions in the business. Vanguard Group Inc. lifted its holdings in shares of Dolby Laboratories by 7.1% in the 1st quarter. Vanguard Group Inc. now owns 7,535,722 shares of the electronics maker's stock valued at $605,194,000 after acquiring an additional 502,110 shares during the last quarter. Bank of New York Mellon Corp lifted its stake in Dolby Laboratories by 18.3% in the first quarter. Bank of New York Mellon Corp now owns 5,709,193 shares of the electronics maker's stock worth $458,505,000 after purchasing an additional 882,716 shares during the last quarter. Mackenzie Financial Corp lifted its stake in Dolby Laboratories by 17.9% in the first quarter. Mackenzie Financial Corp now owns 1,147,800 shares of the electronics maker's stock worth $92,180,000 after purchasing an additional 174,373 shares during the last quarter. Charles Schwab Investment Management Inc. lifted its stake in Dolby Laboratories by 2.1% in the first quarter. Charles Schwab Investment Management Inc. now owns 757,994 shares of the electronics maker's stock worth $60,874,000 after purchasing an additional 15,355 shares during the last quarter. Finally, Northern Trust Corp lifted its stake in Dolby Laboratories by 15.0% in the first quarter. Northern Trust Corp now owns 669,406 shares of the electronics maker's stock worth $53,760,000 after purchasing an additional 87,402 shares during the last quarter. Institutional investors own 58.56% of the company's stock.

Dolby Laboratories Stock Performance

NYSE DLB traded up $0.44 on Thursday, reaching $72.80. 399,571 shares of the company's stock traded hands, compared to its average volume of 433,868. The firm has a market cap of $6.98 billion, a price-to-earnings ratio of 26.67 and a beta of 0.93. The stock has a 50 day moving average price of $74.14 and a 200-day moving average price of $76.03. Dolby Laboratories has a fifty-two week low of $68.24 and a fifty-two week high of $89.66.

Dolby Laboratories (NYSE:DLB - Get Free Report) last posted its earnings results on Thursday, July 31st. The electronics maker reported $0.78 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $0.72 by $0.06. The company had revenue of $315.55 million during the quarter, compared to the consensus estimate of $305.23 million. Dolby Laboratories had a net margin of 19.62% and a return on equity of 11.52%. The firm's quarterly revenue was up 9.2% on a year-over-year basis. During the same period in the previous year, the firm posted $0.71 earnings per share. Dolby Laboratories has set its FY 2025 guidance at 3.880-4.030 EPS. Q4 2025 guidance at 0.610-0.760 EPS. As a group, equities research analysts anticipate that Dolby Laboratories will post 2.94 EPS for the current fiscal year.

Dolby Laboratories Announces Dividend

The firm also recently announced a quarterly dividend, which was paid on Wednesday, August 20th. Investors of record on Tuesday, August 12th were given a dividend of $0.33 per share. The ex-dividend date was Tuesday, August 12th. This represents a $1.32 dividend on an annualized basis and a yield of 1.8%. Dolby Laboratories's payout ratio is currently 48.35%.

Insider Transactions at Dolby Laboratories

In other news, CEO Kevin J. Yeaman sold 39,875 shares of the stock in a transaction dated Tuesday, July 15th. The shares were sold at an average price of $74.82, for a total transaction of $2,983,447.50. Following the sale, the chief executive officer directly owned 114,725 shares of the company's stock, valued at $8,583,724.50. This represents a 25.79% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is available through this link. Also, SVP Shriram Revankar sold 7,000 shares of the stock in a transaction dated Friday, August 22nd. The stock was sold at an average price of $74.92, for a total transaction of $524,440.00. Following the sale, the senior vice president directly owned 70,435 shares in the company, valued at approximately $5,276,990.20. The trade was a 9.04% decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last quarter, insiders sold 133,049 shares of company stock valued at $9,920,281. Insiders own 38.39% of the company's stock.

Wall Street Analyst Weigh In

Several analysts have issued reports on DLB shares. Rosenblatt Securities reissued a "buy" rating and issued a $95.00 price objective on shares of Dolby Laboratories in a research note on Friday, August 1st. Tigress Financial raised their target price on shares of Dolby Laboratories from $112.00 to $114.00 and gave the stock a "buy" rating in a research report on Friday, August 15th. Finally, Wall Street Zen raised shares of Dolby Laboratories from a "hold" rating to a "buy" rating in a report on Saturday, August 30th. Three research analysts have rated the stock with a Buy rating, According to MarketBeat, the stock presently has an average rating of "Buy" and an average target price of $103.00.

Get Our Latest Report on Dolby Laboratories

Dolby Laboratories Company Profile

(Free Report)

Dolby Laboratories, Inc creates audio and imaging technologies that transform entertainment at the cinema, DTV transmissions and devices, mobile devices, OTT video and music services, home entertainment devices, and automobiles. The company develops and licenses its audio technologies, such as AAC & HE-AAC, a digital audio codec solution used for a range of media applications; AVC, a digital video codec with high bandwidth efficiency used in various media devices; Dolby AC-4, a digital audio coding technology that delivers new audio experiences to a range of playback devices; and Dolby Atmos technology for cinema and various media devices.

See Also

Institutional Ownership by Quarter for Dolby Laboratories (NYSE:DLB)

Should You Invest $1,000 in Dolby Laboratories Right Now?

Before you consider Dolby Laboratories, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Dolby Laboratories wasn't on the list.

While Dolby Laboratories currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

These 7 Stocks Will Be Magnificent in 2025 Cover

Discover the next wave of investment opportunities with our report, 7 Stocks That Will Be Magnificent in 2025. Explore companies poised to replicate the growth, innovation, and value creation of the tech giants dominating today's markets.

Get This Free Report
Like this article? Share it with a colleague.